Kylie O'Keefe
CIK: 0002118100
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (50.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
QURE
uniQure N.V.
Officer
Discretionary Trading P&L
Holdings
About O'Keefe Kylie
O'Keefe Kylie (SEC CIK 0002118100) files insider reports with the SEC as Chief Customer & Strat Officer of uniQure N.V. (QURE).
Signal8 holds 3 ownership filings by O'Keefe Kylie (1 Form 3, 2 Form 4), filed between Mar 9, 2026 and Jun 12, 2026. Those filings report 2 transactions, from Mar 4, 2026 to Jun 11, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on O'Keefe Kylie's filings is in AMSTERDAM.
Recent filings by O'Keefe Kylie
Other insiders filing for uniQure N.V. (QURE)
- Abi-Saab Walid, Chief Medical Officer
- Kapusta Matthew C, CEO, Managing Director
- Kaye Jack, Director
- Balachandran Madhavan, Director
- Potts Jeannette, Chief Legal Officer
- Meek David D., Director